ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1354

Improving the Measurement of Disease Activity for Patients with Rheumatoid Arthritis: Validation of an Electronic Version of the Routine Assessment of Patient Index Data (RAPID 3)

Ruthie May Chua1, John Mecchella2,3 and Alicia Zbehlik4,5, 1Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, 2Geisel School of Medicine at Dartmouth, Hanover, NH, 3Dartmouth Hitchcock Medical Center, Lebanon, NH, 4Rheumatology, Dartmouth-Hitchcock Med Ctr, Lebanon, NH, 5The Geisel School of Medicine at Dartmouth, The Dartmouth Centers for Health and Aging, The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Disease Activity, Electronic Health Record, patient-reported outcome measures and quality measures

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Quality Measures and Quality of Care

Session Type: Abstract Submissions (ACR)

Background/Purpose

Quantitative measures of disease activity are associated with improved outcomes for patients with rheumatoid arthritis (RA), but many rheumatologists continue to rely on non-quantitative assessments. The Dartmouth-Hitchcock Medical Center (DHMC) electronic health record (EHR) does not currently support patient-reported outcome measures (PROMs) to assess RA activity that can be searched and aggregated for patient care, research, or system-based quality improvement. The Routine Assessment of Patient Index Data 3 (RAPID 3) is a validated PROM which evaluates physical function, pain and global health. To integrate the RAPID 3 into routine clinical practice, an electronic version was built to allow patients to complete the RAPID3 through the EHR. Because we could not replicate the exact visual presentation of the RAPID 3 in the EHR, the aim of this study was to demonstrate equivalence between the electronic RAPID 3 and the validated paper version.

Methods

From March to June 2014, patients in the Rheumatology clinic age ≥ 18 years with seropositive or  seronegative RA were identified. All participants were active users of the web-based patient portal of the EHR. The electronic RAPID 3 was sent via the patient portal to each participant 1 week prior to their  appointment. Patients were notified electronically and by phone to complete the survey. The RAPID 3 paper version was administered on the day of their clinic visit. The first 50 patients to complete both versions were included. The EHR automatically calculates and interprets the disease activity score (scale 0-30: >12 high; 6.1-12 moderate; and 3.1-6 low; ≤3 remission). Paper surveys were scored manually. A paired t-test was used to compare samples with p values of ≤0.05 considered significant. The study was exempt from review by the Committee for the Protection of Human Subjects at Dartmouth College.

Results

Of the 50 patients included in the study, 33 (66%) were female and the average age was 58.8 years (±12.27).  An average of 4.2 days passed between the assessments. The mean total RAPID 3 scores for the paper and EHR versions were 9.57(SD±6.45) and 9.75 (SD±6.46) respectively. There were no statistically significant differences between the mean total RAPID3 of the paper and electronic versions (p=0.46), or each component score (table 1).

Table 1. Comparison of paper and EHR versions of RAPID3.

 

Mean (±Standard Deviation)

paired t- test p value

 

 

Paper

EHR

Physical Function

1.87(1.91)

1.85 (1.83)

0.85

    Dress yourself

0.40 (0.64)

0.42 (0.67)

0.36

    Get in and out of bed

0.46 (0.61)

0.34 (0.59)

0.41

    Lift full cup or glass to mouth

0.20 (0.53)

0.18 (0.56)

0.37

    Walking outdoors on flat ground

0.40 (0.67)

0.40 (0.67)

0.50

    Wash and dry your entire body

0.42 (0.64)

0.48 (0.68)

0.36

    Bend down to pick up clothing from floor

0.48 (0.68)

0.50 (0.68)

0.50

    Turn regular faucet on and off

0.20 (0.53)

0.20 (0.53)

0.50

    Get in and out of a car, bus, train or airplane

0.54 (0.65)

0.50 (0.58)

0.23

    Walk two miles or three kilometers, if you wish

1.20 (1.18)

1.20 (1.20)

0.46

    Participate in recreational activities and sports

1.28 (1.03)

1.34 (1.08)

0.37

 

 

 

 

Pain Score

3.86 (2.64)

4.03 (2.65)

0.27

Patient Global Assessment

3.84 (2.75)

3.87 (2.80)

0.65

 

 

 

 

Total

9.57 (6.45)

9.75 (6.46)

0.46

 Conclusion

There was no significant difference in responses between the electronic and paper versions. The electronic RAPID3 (built in an Epic system v2010) can and should be included in the care of all RA patients without interrupting clinic flow, and will facilitate research and systems-based practice improvement.


Disclosure:

R. M. Chua,
None;

J. Mecchella,
None;

A. Zbehlik,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-the-measurement-of-disease-activity-for-patients-with-rheumatoid-arthritis-validation-of-an-electronic-version-of-the-routine-assessment-of-patient-index-data-rapid-3/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology